Committees

Agenda for the 182ND meeting of the Medicines Adverse Reactions Committee to be held on Thursday 11 JUNE 2020, at 9 am

1.	MATTERS OF ADMINISTRATION
1.1	Welcome and apologies
1.2	Minutes and recommendations of the 181st MARC meeting
1.3	Declarations of potential conflicts of interest
2.	MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE
2.1	CARM quarterly report
3.	PHARMACOVIGILANCE REPORTS
3.1	Matters referred to the MARC under section 36 of the Medicines Act 1981
	3.1.1 Consideration of Cathejell (lignocaine) 2% gel under section 36 of the Medicines Act 1981
3.2	Matters referred to the MARC by Medsafe
	3.2.1 Antiepileptic medicines and neurodevelopmental
	3.2.2 Fluconazole and use in pregnancy
	3.2.3 Use of oral sedating antihistamines in children for sedation
	3.2.4 Protease inhibitors for Hepatitis C and risk of serious liver injury
4.	MEDSAFE PHARMACOVIGILANCE ACTIVITIES
4.1	Report on standing agenda items
4.2	Medsafe pharmacovigilance activities
4.3	Prescriber Update
4.4	Quarterly summary of recent safety communications
5.	OTHER BUSINESS